Alzheimer's disease as proteolytic disorders: anabolism and catabolism of beta-amyloid (Q41751572)

8 October 2017

1 reference

title

Alzheimer's disease as proteolytic disorders: anabolism and catabolism of beta-amyloid (English)

1 reference

8 October 2017

0 references

1 reference

Saido TC

1

1 reference

8 October 2017

1 January 1998

1 reference

8 October 2017

Neurobiology of Aging

1 reference

8 October 2017

19

1 reference

8 October 2017

1 Suppl

1 reference

8 October 2017

S69-75

1 reference

Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo

8 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900033-5

7 January 2021

Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900033-5

7 January 2021

Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900033-5

7 January 2021

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900033-5

7 January 2021

Amyloid beta protein (A beta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43).

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900033-5

7 January 2021

Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta-peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900033-5

7 January 2021

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900033-5

7 January 2021

Decrease in cytosolic Aspartyl-aminopeptidase but not in Alanyl-aminopeptidase activity in the frontal cortex of the aged rat

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900033-5

7 January 2021

Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43).

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900033-5

7 January 2021

Reduction of plasma glutamyl aminopeptidase activity in sporadic Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900033-5

7 January 2021

The E280A presenilin 1 Alzheimer mutation produces increased A beta 42 deposition and severe cerebellar pathology.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900033-5

7 January 2021

The site of the earliest lesions of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900033-5

7 January 2021

Amyloid beta protein (Abeta) deposition in chromosome 14-linked Alzheimer's disease: predominance of Abeta42(43).

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900033-5

7 January 2021

Amino-terminal deletions enhance aggregation of beta-amyloid peptides in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900033-5

7 January 2021

Daily rhythm of aspartate aminopeptidase activity in the retina, pineal gland and occipital cortex of the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900033-5

7 January 2021

Heterogeneity of water-soluble amyloid beta-peptide in Alzheimer's disease and Down's syndrome brains.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900033-5

7 January 2021

Dominant and differential deposition of distinct beta-amyloid peptide species, A beta N3(pE), in senile plaques.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900033-5

7 January 2021

Amino- and carboxyl-terminal heterogeneity of beta-amyloid peptides deposited in human brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900033-5

7 January 2021

Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900033-5

7 January 2021

Production of the Alzheimer amyloid beta protein by normal proteolytic processing

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900033-5

7 January 2021

Role of the beta-amyloid protein in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900033-5

7 January 2021

An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900033-5

7 January 2021

The presenilin 2 mutation (N141I) linked to familial Alzheimer disease (Volga German families) increases the secretion of amyloid beta protein ending at the 42nd (or 43rd) residue

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900033-5

7 January 2021

10.1016/S0197-4580(98)00033-5

Identifiers

DOI

1 reference

8 October 2017

1 reference

PubMed ID

9562472